182 related articles for article (PubMed ID: 21953510)
41. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
[TBL] [Abstract][Full Text] [Related]
42. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
[TBL] [Abstract][Full Text] [Related]
43. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.
Menendez P; Catalina P; Rodríguez R; Melen GJ; Bueno C; Arriero M; García-Sánchez F; Lassaletta A; García-Sanz R; García-Castro J
J Exp Med; 2009 Dec; 206(13):3131-41. PubMed ID: 19995953
[TBL] [Abstract][Full Text] [Related]
44. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Blanco JG; Dervieux T; Edick MJ; Mehta PK; Rubnitz JE; Shurtleff S; Raimondi SC; Behm FG; Pui CH; Relling MV
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10338-43. PubMed ID: 11526240
[TBL] [Abstract][Full Text] [Related]
45. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
[TBL] [Abstract][Full Text] [Related]
46. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia.
Pui CH; Campana D
Leukemia; 2007 Apr; 21(4):593-4. PubMed ID: 17301807
[No Abstract] [Full Text] [Related]
47. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.
Hu H; Saha N; Yang Y; Ahmad E; Lachowski L; Shrestha U; Premkumar V; Ropa J; Chen L; Teahan B; Grigsby S; Marschalek R; Nikolovska-Coleska Z; Muntean AG
Leukemia; 2023 Jan; 37(1):190-201. PubMed ID: 36435883
[TBL] [Abstract][Full Text] [Related]
48. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW
Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461
[TBL] [Abstract][Full Text] [Related]
49. [Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].
Huang S; Yang H; Gao L; Dou LP; Xu YY; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1435-40. PubMed ID: 24370025
[TBL] [Abstract][Full Text] [Related]
50. The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.
Marks DI; Moorman AV; Chilton L; Paietta E; Enshaie A; DeWald G; Harrison CJ; Fielding AK; Foroni L; Goldstone AH; Litzow MR; Luger SM; McMillan AK; Racevskis J; Rowe JM; Tallman MS; Wiernik P; Lazarus HM
Haematologica; 2013 Jun; 98(6):945-52. PubMed ID: 23349309
[TBL] [Abstract][Full Text] [Related]
51. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334
[TBL] [Abstract][Full Text] [Related]
52. MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia.
Eguchi M; Eguchi-Ishimae M; Knight D; Kearney L; Slany R; Greaves M
Genes Chromosomes Cancer; 2006 Aug; 45(8):754-60. PubMed ID: 16688745
[TBL] [Abstract][Full Text] [Related]
53. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
[TBL] [Abstract][Full Text] [Related]
54. Lymphoblastic lymphoma with mature b-cell immunophenotype and MLL-AF9 in a child.
Takachi T; Iwabuchi H; Imamura M; Imai C
Pediatr Blood Cancer; 2011 Dec; 57(7):1251-2. PubMed ID: 21681937
[No Abstract] [Full Text] [Related]
55. Transcription control by the ENL YEATS domain in acute leukaemia.
Erb MA; Scott TG; Li BE; Xie H; Paulk J; Seo HS; Souza A; Roberts JM; Dastjerdi S; Buckley DL; Sanjana NE; Shalem O; Nabet B; Zeid R; Offei-Addo NK; Dhe-Paganon S; Zhang F; Orkin SH; Winter GE; Bradner JE
Nature; 2017 Mar; 543(7644):270-274. PubMed ID: 28241139
[TBL] [Abstract][Full Text] [Related]
56. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
[TBL] [Abstract][Full Text] [Related]
57. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.
Jiao Y; Cui L; Gao C; Li W; Zhao X; Liu S; Wu M; Deng G; Li Z
Leuk Res; 2012 Jan; 36(1):67-71. PubMed ID: 21696825
[TBL] [Abstract][Full Text] [Related]
58. MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells.
Maethner E; Garcia-Cuellar MP; Breitinger C; Takacova S; Divoky V; Hess JL; Slany RK
Cell Rep; 2013 May; 3(5):1553-66. PubMed ID: 23623499
[TBL] [Abstract][Full Text] [Related]
59. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo.
Takacova S; Slany R; Bartkova J; Stranecky V; Dolezel P; Luzna P; Bartek J; Divoky V
Cancer Cell; 2012 Apr; 21(4):517-31. PubMed ID: 22516260
[TBL] [Abstract][Full Text] [Related]
60. The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
Sun YN; Hu YX; Gao L; Xiao PF; Lu J; Wu SY; Wang M; Shao XJ; Zhou CY; Ling J; Li JQ; Pan J; Gao J; Hu SY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6020-6029. PubMed ID: 30280786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
